However, sh-DNMT1 tumor-bearing mice exhibited a slightly greater level of p-GSK3β than nontreated xenografted mice, suggesting that glycogen depredation in sh-DNMT1 tumors themselves may also trigger compensatory liver glycogen metabolism to a certain extent. This evidence concerns the gene DNMT1 and neoplasm.